BMS-986202

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986202, covering 2017-08-03 to 2017-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis [Phase 1]